bg
V

Viking Therapeutics (VKTX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Viking Therapeutics (VKTX)

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Company's clinical program, VK5211, is an orally available drug candidate, which i... Read more

  • USD20.78
  • USD22.19
  • USD20.66
  • USD25.72
  • 9.00%
  • --
  • 200.00
  • 3.21M
  • 2.1B
  • 2.02
  • 838.80%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.